Literature DB >> 2446140

A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells.

C Morimoto1, C E Rudd, N L Letvin, S F Schlossman.   

Abstract

The CD4 subset of cells displays helper/inducer activity and recognizes class II antigens of the major histocompatibility complex (MHC), while the CD8 subset recognizes class I MHC antigens and exhibits cytotoxic or suppressor function. Considerable functional as well as corresponding phenotypic heterogeneity exists within the two major T cell subsets. Although the CD8+ population contains pre-cytotoxic, cytotoxic, pre-suppressor and suppressor effector T cells, these distinctions still rest largely on the use of functional assays. Attempts have been made to define the CD8+ precursor of the killer cell with new monoclonal antibodies. But more precise phenotypic distinctions between the functional subpopulations within CD8+ cells will be needed. We have now developed a monoclonal antibody, anti-S6F1 which can distinguish killer effector and suppressor effector cells in CD8 lymphocyte populations. The cell-surface structure defined by this antibody comprises two glycoproteins with relative molecular mass (Mr) 180K and 95K respectively. Also sequential immunoprecipitation studies and two dimensional gel electrophoresis indicate that anti-S6F1 recognizes a novel epitope on the LFA-1 antigen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446140     DOI: 10.1038/330479a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  25 in total

1.  Lymphocyte subsets in subjects exposed to asbestos: changes in circulating natural killer cells.

Authors:  N al Jarad; M Macey; S Uthayakumar; A C Newland; R M Rudd
Journal:  Br J Ind Med       Date:  1992-11

2.  Differences in systemic and central nervous system cellular immunity relevant to relapsing-remitting multiple sclerosis.

Authors:  Makoto Matsui; Shin-ichi Araya; Hui-Yun Wang; Kouji Matsushima; Takahiko Saida
Journal:  J Neurol       Date:  2005-03-21       Impact factor: 4.849

3.  Prognostic significance of cytotoxic T cells in individuals infected with human immunodeficiency virus.

Authors:  C Mihailov; A Lamour; V Beaudré-Bellein; N Jézequel; M Garré; D Mottier; G Guillet; P Youinou
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

4.  Age-related changes in surface antigens on peripheral lymphocytes of healthy children.

Authors:  Y Osugi; J Hara; H Kurahashi; N Sakata; M Inoue; K Yumura-Yagi; K Kawa-Ha; S Okada; A Tawa
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

5.  Age-related ranges of memory, activation, and cytotoxic markers on CD4 and CD8 cells in children.

Authors:  M C Aldhous; G M Raab; K V Doherty; J Y Mok; A G Bird; K S Froebel
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

6.  Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity.

Authors:  K C Watret; J A Whitelaw; K S Froebel; A G Bird
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

7.  Phenotypical and functional evaluation of CD8+/S6F1+ T lymphocytes in haemophiliac individuals with HIV-1 infection.

Authors:  F Cavallin; A Traldi; R Zambello
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

8.  Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma.

Authors:  S Koyama; T Ebihara; K Fukao
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.

Authors:  R B Lal; D L Rudolph; D S Schmid; M D Lairmore
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

10.  Phenotypic expression of integrin membrane receptors on spontaneously proliferating CD8 cells in human T-lymphotropic virus type II (HTLV-II)-infected individuals.

Authors:  R B Lal; D L Rudolph; T Rowe; T M Folks
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.